Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127873091 | 12787309 | 1 | I | 20160907 | 0 | 20160927 | 20160927 | DIR | FDA-CTU | 65.00 | YR | M | N | 108.90000 | KG | 20160927 | N | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127873091 | 12787309 | 1 | PS | CETUXIMAB | CETUXIMAB | 1 | Intravenous (not otherwise specified) | Y | D | 0 | 900 | MG | 1X |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127873091 | 12787309 | 1 | Laryngeal squamous cell carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127873091 | 12787309 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127873091 | 12787309 | Back pain | |
127873091 | 12787309 | Blood pressure systolic decreased | |
127873091 | 12787309 | Defaecation urgency | |
127873091 | 12787309 | Dizziness | |
127873091 | 12787309 | Hyperhidrosis | |
127873091 | 12787309 | Myalgia | |
127873091 | 12787309 | Nausea | |
127873091 | 12787309 | Pyrexia | |
127873091 | 12787309 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
127873091 | 12787309 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127873091 | 12787309 | 1 | 20160907 | 20160907 | 0 |